Next Article in Journal
Computational Inference of Gene Co-Expression Networks for the identification of Lung Carcinoma Biomarkers: An Ensemble Approach
Next Article in Special Issue
Transcriptome Meta-Analysis Deciphers a Dysregulation in Immune Response-Associated Gene Signatures during Sepsis
Previous Article in Journal
The Hearing Impairment Ontology: A Tool for Unifying Hearing Impairment Knowledge to Enhance Collaborative Research
Previous Article in Special Issue
Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells
Open AccessReview

A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer

1
Indian Institute of Management Ahmedabad (IIMA), Gujarat 380015, India
2
Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida 201306, India
3
Department of Life Science, School of Basic Science & Research (SBSR), Sharda University, Greater Noida 201306, India
4
National Centre of Experimental Mineralogy & Petrology (NCEMP), University of Allahabad, Prayagraj 2l1002, India
*
Author to whom correspondence should be addressed.
Genes 2019, 10(12), 961; https://doi.org/10.3390/genes10120961
Received: 29 August 2019 / Revised: 14 November 2019 / Accepted: 18 November 2019 / Published: 22 November 2019
(This article belongs to the Special Issue The Role of Genotoxicity in Infertility and Cancer Development)
Notch signaling is a primitive signaling pathway having various roles in the normal origin and development of each multicellular organisms. Therefore, any aberration in the pathway will inevitably lead to deadly outcomes such as cancer. It has now been more than two decades since Notch was acknowledged as an oncogene in mouse mammary tumor virus-infected mice. Since that discovery, activated Notch signaling and consequent up-regulation of tumor-promoting Notch target genes have been observed in human breast cancer. Moreover, consistent over-expression of Notch ligands and receptors has been shown to correlate with poor prognosis in human breast cancer. Notch regulates a number of key processes during breast carcinogenesis, of which, one key phenomenon is epithelial–mesenchymal transition (EMT). EMT is a key process for large-scale cell movement during morphogenesis at the time of embryonic development. Cancer cells aided by transcription factors usurp this developmental program to execute the multi-step process of tumorigenesis and metastasis. In this review, we recapitulate recent progress in breast cancer research that has provided new perceptions into the molecular mechanisms behind Notch-mediated EMT regulation during breast tumorigenesis. View Full-Text
Keywords: Notch; EMT; breast cancer; metastasis; invasion; signaling pathway; hypoxia; cytokine; PI3K/Akt Notch; EMT; breast cancer; metastasis; invasion; signaling pathway; hypoxia; cytokine; PI3K/Akt
Show Figures

Figure 1

MDPI and ACS Style

Kar, R.; Jha, N.K.; Jha, S.K.; Sharma, A.; Dholpuria, S.; Asthana, N.; Chaurasiya, K.; Singh, V.K.; Burgee, S.; Nand, P. A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer. Genes 2019, 10, 961.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop